太烂了
app强制升级，买一点药，十几天才到货
Free
About
A legitimate online platform for purchasing and wholesale of pharmaceuticals, medical devices, and health products. It integrates virtual networks with physical logistics for convenient online ordering, payment, and offline delivery, offering smart procurement and price comparison.
✓Online pharmaceutical procurement
✓Wholesale of medicines and medical devices
✓E-commerce transaction platform
✓Smart procurement and price comparison
✓Integrated logistics and distribution
✓Secure payment and quality assurance
Show original description
What's New in 药易购
5.6.7
July 3, 2026
我们进行了改进并修正了一些错误，为你提供更好的体验。
User reviews
Developer apps
FAQ
What types of products can I purchase on 药易购?
药易购 offers a wide range of products including Western medicines, traditional Chinese medicines, OTC drugs, medical devices, Chinese herbal pieces, health supplements, food, chemical drugs, and biological products.
How does 药易购 ensure the safety and quality of its products?
The platform is a legitimate online trading platform approved by the National Medical Products Administration. It guarantees the safety of your funds and the quality of the medicines, providing secure procurement and sales services.
What are the key features of 药易购's procurement service?
药易购 provides a one-stop convenient online procurement service for retail terminals. It features online ordering, online payment, centralized warehousing, offline distribution, intelligent procurement, and intelligent price comparison.
Is 药易购 available on multiple devices?
Yes, 药易购 is supported on iPhone, iPad, and iPod devices, allowing for flexible access to its services.
What is the age rating for 药易购?
The app has an age rating of 17+, indicating it is intended for mature users.
How often is 药易购 updated?
The latest version of 药易购 is 5.6.4, and it was last updated on May 29, 2026. This suggests a relatively active update schedule.
Does 药易购 have ads?
No, the application does not contain advertisements.
What is the user rating for 药易购?
药易购 has a rating of 3.0 stars based on 2 ratings, which suggests a mixed user reception.
